相似文献
1
Commentary: Coronary revascularization therapies and number needed to treat.
JTCVS Open. 2022 Jan 20;9:112-113. doi: 10.1016/j.xjon.2022.01.012. eCollection 2022 Mar.
2
[Coronary angioplasty in elderly patients].
Ital Heart J Suppl. 2002 Jan;3(1):1-8.
3
Robotic advanced hybrid coronary revascularization: Outcomes with two internal thoracic artery grafts and stents.
JTCVS Tech. 2022 Aug 27;16:76-88. doi: 10.1016/j.xjtc.2022.08.012. eCollection 2022 Dec.
4
Synergistic Effect of Transmyocardial Revascularization and Platelet-Rich Plasma on Improving Cardiac Function After Coronary Artery Bypass Grafting.
Cureus. 2024 May 14;16(5):e60254. doi: 10.7759/cureus.60254. eCollection 2024 May.
5
Perioperative management of patients undergoing transmyocardial laser revascularization.
Semin Thorac Cardiovasc Surg. 2006 Spring;18(1):58-67. doi: 10.1053/j.semtcvs.2006.04.003.
6
Alternatives to traditional coronary bypass surgery.
Semin Thorac Cardiovasc Surg. 2002 Jan;14(1):110-8. doi: 10.1053/stcs.2002.31896.
7
Lipid lowering versus revascularization: an idea whose time (for testing) has come.
Circulation. 1997 Aug 19;96(4):1360-2. doi: 10.1161/01.cir.96.4.1360.
8
Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).
Am Heart J. 2005 Mar;149(3):512-9. doi: 10.1016/j.ahj.2004.10.010.
9
Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease.
Cardiol Ther. 2013 Jun;2(1):69-84. doi: 10.1007/s40119-013-0014-3. Epub 2013 Mar 26.
10
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010.
本文引用的文献
1
The magnitude of the survival benefit of internal thoracic artery grafting: Absolute risk reduction.
JTCVS Open. 2021 Nov 20;9:106-111. doi: 10.1016/j.xjon.2021.11.008. eCollection 2022 Mar.
2
Right Internal Thoracic Artery Patency Is Affected More by Target Choice Than Conduit Configuration.
Ann Thorac Surg. 2022 Aug;114(2):458-466. doi: 10.1016/j.athoracsur.2021.09.015. Epub 2021 Oct 20.
3
Coronary Artery Target Selection and Survival After Bilateral Internal Thoracic Artery Grafting.
J Am Coll Cardiol. 2020 Jan 28;75(3):258-268. doi: 10.1016/j.jacc.2019.11.026.
4
An alternative approach for estimating the number needed to treat for survival endpoints.
PLoS One. 2019 Oct 18;14(10):e0223301. doi: 10.1371/journal.pone.0223301. eCollection 2019.
5
PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week.
J Am Coll Cardiol. 2019 Mar 5;73(8):964-976. doi: 10.1016/j.jacc.2018.11.053.
6
Calculating the number needed to treat for trials where the outcome is time to an event.
BMJ. 1999 Dec 4;319(7223):1492-5. doi: 10.1136/bmj.319.7223.1492.
7
Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events.
N Engl J Med. 1986 Jan 2;314(1):1-6. doi: 10.1056/NEJM198601023140101.
Zotero 插件